18380893

Source:http://linkedlifedata.com/resource/pubmed/id/18380893

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0069515, umls-concept:C0079419, umls-concept:C0205210, umls-concept:C0242957, umls-concept:C0376515, umls-concept:C0677874, umls-concept:C0678222, umls-concept:C0871261, umls-concept:C1511572, umls-concept:C1521733, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C1707455, umls-concept:C2347669, umls-concept:C2911692
pubmed:issue	2
pubmed:dateCreated	2008-5-29
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00543829
pubmed:abstractText	To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-10080586, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-10206072, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-10426456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-10561250, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-10732784, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-11481357, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-11896092, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-12237246, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-1340170, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-14731839, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-15292386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-15597216, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-15598940, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-16892838, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-1757079, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-6206131, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-7600279, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-7641210, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-8001751, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-8080680, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-8912545, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9207459, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9376273, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9495354, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9605801, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9704717, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9747866, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9797688, http://linkedlifedata.com/resource/pubmed/commentcorrection/18380893-9928582
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100927353
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:issn	1465-542X
pubmed:author	pubmed-author:BlohmerJens-UweJU, pubmed-author:CaputoAngelikaA, pubmed-author:CostaSerban DSD, pubmed-author:EidtmannHolgerH, pubmed-author:German Breast Group, pubmed-author:HilfrichJörnJ, pubmed-author:JackischChristianC, pubmed-author:KaufmannManfredM, pubmed-author:LoiblSibylleS, pubmed-author:MerkleElisabethE, pubmed-author:RaabGünterG, pubmed-author:SinnHans-PeterHP, pubmed-author:von MinckwitzGunterG
pubmed:issnType	Electronic
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R30
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:18380893-Humans, pubmed-meshheading:18380893-Breast Neoplasms, pubmed-meshheading:18380893-Prospective Studies, pubmed-meshheading:18380893-Aged, pubmed-meshheading:18380893-Female, pubmed-meshheading:18380893-Mastectomy, pubmed-meshheading:18380893-Treatment Outcome, pubmed-meshheading:18380893-Adult, pubmed-meshheading:18380893-Middle Aged, pubmed-meshheading:18380893-Lymphatic Metastasis, pubmed-meshheading:18380893-Analysis of Variance, pubmed-meshheading:18380893-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18380893-Predictive Value of Tests, pubmed-meshheading:18380893-Neoadjuvant Therapy, pubmed-meshheading:18380893-Immunohistochemistry

More...